• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Image Guided Therapy System Market

    ID: MRFR/HC/41272-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Image Guided Therapy System Market Research Report: By Application (Cardiology, Oncology, Orthopedics, Neurology, Gastroenterology), By Technology (Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Fluoroscopy), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutions), By Product Type (Systems, Software, Accessories) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Image Guided Therapy System Market Infographic
    Purchase Options

    Image Guided Therapy System Market Summary

    As per MRFR analysis, the Image Guided Therapy System Market Size was estimated at 5.407 USD Billion in 2024. The Image Guided Therapy System industry is projected to grow from 5.743 USD Billion in 2025 to 10.5 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.22 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Image Guided Therapy System Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

    • North America remains the largest market for image guided therapy systems, driven by advanced healthcare infrastructure.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and population health needs.
    • Cardiology continues to dominate the market as the largest segment, while oncology is rapidly gaining traction as the fastest-growing segment.
    • Technological advancements in imaging techniques and the rising demand for minimally invasive procedures are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 5.407 (USD Billion)
    2035 Market Size 10.5 (USD Billion)
    CAGR (2025 - 2035) 6.22%

    Major Players

    Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Medtronic (US), Hitachi Medical Systems (JP), Hologic (US), Fujifilm Holdings (JP), Samsung Medison (KR)

    Image Guided Therapy System Market Trends

    The Image Guided Therapy System Market is currently experiencing a transformative phase, driven by advancements in technology and increasing demand for minimally invasive procedures. The integration of imaging modalities such as MRI, CT, and ultrasound into therapeutic interventions enhances precision and efficacy, thereby improving patient outcomes. As healthcare providers seek to optimize operational efficiency and reduce recovery times, the adoption of these systems appears to be on the rise. Furthermore, the growing emphasis on personalized medicine suggests that tailored treatment approaches facilitated by image guidance are becoming more prevalent. In addition, the market landscape is evolving due to the increasing prevalence of chronic diseases and the aging population, which necessitates innovative treatment solutions. The potential for enhanced diagnostic capabilities and real-time monitoring during procedures indicates a promising future for the Image Guided Therapy System Market. As stakeholders continue to invest in research and development, the emergence of novel technologies and applications may further propel market growth, creating opportunities for both established players and new entrants in the field.

    Technological Advancements

    Recent innovations in imaging technologies are significantly enhancing the capabilities of image guided therapy systems. The development of high-resolution imaging and real-time visualization tools is likely to improve the accuracy of procedures, thereby reducing complications and enhancing patient safety.

    Rising Demand for Minimally Invasive Procedures

    There is a growing preference among patients and healthcare providers for minimally invasive techniques, which are associated with shorter recovery times and reduced hospital stays. This trend is driving the adoption of image guided therapy systems, as they facilitate such procedures effectively.

    Focus on Personalized Medicine

    The shift towards personalized medicine is influencing the Image Guided Therapy System Market, as healthcare professionals increasingly seek tailored treatment options. This trend suggests that systems capable of providing precise imaging and targeted interventions will be in higher demand.

    The ongoing advancements in imaging technologies and the increasing demand for minimally invasive procedures appear to be driving the evolution of the global image-guided therapy system market, suggesting a transformative shift in patient care methodologies.

    U.S. Food and Drug Administration (FDA)

    Image Guided Therapy System Market Drivers

    Focus on Personalized Medicine

    The emphasis on personalized medicine is reshaping the landscape of the Image Guided Therapy System Market. Tailoring treatment plans to individual patient needs enhances the effectiveness of therapies and minimizes adverse effects. Image-guided systems play a crucial role in this paradigm shift by providing precise imaging that informs personalized treatment strategies. The market for personalized medicine is anticipated to reach USD 2 trillion by 2025, indicating a robust growth trajectory. This focus on individualized care is driving healthcare providers to adopt advanced imaging technologies, thereby propelling the growth of the Image Guided Therapy System Market.

    Government Initiatives and Funding

    Government initiatives and funding aimed at improving healthcare infrastructure are pivotal drivers for the Image Guided Therapy System Market. Various governments are investing in advanced medical technologies to enhance healthcare delivery and patient outcomes. For instance, funding programs for research and development in imaging technologies are fostering innovation and accessibility. These initiatives are likely to increase the adoption of image-guided therapies across healthcare facilities. As governments prioritize healthcare advancements, the market is expected to benefit from increased investments, which could lead to a projected growth rate of 7% annually in the Image Guided Therapy System Market.

    Increasing Prevalence of Chronic Diseases

    The rising prevalence of chronic diseases, including cancer, cardiovascular disorders, and neurological conditions, is a significant driver for the Image Guided Therapy System Market. As these diseases require precise and effective treatment modalities, the demand for image-guided therapies is likely to escalate. According to recent statistics, chronic diseases account for approximately 70% of all deaths worldwide, underscoring the urgent need for advanced therapeutic solutions. This trend is prompting healthcare facilities to invest in image-guided systems, which are essential for accurate diagnosis and treatment planning. Consequently, the market is expected to witness substantial growth as healthcare providers seek to enhance their treatment capabilities.

    Rising Demand for Minimally Invasive Procedures

    The growing preference for minimally invasive procedures is significantly influencing the Image Guided Therapy System Market. Patients and healthcare professionals alike favor these techniques due to their associated benefits, such as reduced recovery times, lower risk of complications, and minimal scarring. As a result, there is an increasing adoption of image-guided therapies that facilitate these procedures. The market for minimally invasive surgical instruments is projected to grow at a CAGR of 8% over the next five years, reflecting the shift towards less invasive treatment options. This trend is likely to bolster the demand for advanced imaging systems that support minimally invasive interventions in the Image Guided Therapy System Market.

    Technological Advancements in Imaging Techniques

    The Image Guided Therapy System Market is experiencing a surge in technological advancements, particularly in imaging techniques such as MRI, CT, and ultrasound. These innovations enhance the precision and accuracy of diagnostic procedures, thereby improving patient outcomes. For instance, the integration of artificial intelligence in imaging systems is streamlining workflows and reducing the time required for image acquisition and interpretation. As a result, healthcare providers are increasingly adopting these advanced systems, which is expected to drive market growth. The market for imaging systems is projected to reach USD 50 billion by 2026, indicating a robust demand for innovative solutions in the Image Guided Therapy System Market.

    Market Segment Insights

    By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing)

    In the Image Guided Therapy System Market, the application segments are distributed among Cardiology, Oncology, Orthopedics, Neurology, and Gastroenterology, with Cardiology holding the largest share. The significance of image-guided interventions in cardiac procedures has propelled Cardiology to the forefront, serving as a primary driver for adoption. While Cardiology remains dominant, Oncology is emerging as the fastest-growing segment due to rising incidences of cancer across the globe, necessitating innovative therapies that leverage imaging technology for enhanced precision and patient outcomes.

    Cardiology (Dominant) vs. Oncology (Emerging)

    Cardiology as a dominant segment showcases the critical role of image-guided therapies such as intravascular ultrasound and fluoroscopy, which enable physicians to visualize complex cardiac anatomy and perform interventions effectively. Meanwhile, Oncology represents an emerging segment that is rapidly evolving, propelled by advancements in imaging technologies like PET and MRI. These technologies are ensuring accurate targeting of tumors while minimizing collateral damage to surrounding tissues, thus enhancing the efficacy of cancer treatments. The surge in demand for minimally invasive options is further driving innovations in this sector, fostering a robust competitive landscape among medical device manufacturers.

    By Technology: Ultrasound (Largest) vs. Magnetic Resonance Imaging (Fastest-Growing)

    In the Image Guided Therapy System Market, the share distribution among various technologies reveals Ultrasound as the largest segment, widely adopted due to its cost-effectiveness and versatility in a variety of diagnostic environments. In contrast, Magnetic Resonance Imaging (MRI) is emerging as a rapidly expanding segment, gaining traction due to advancements in technology that enhance image quality and diagnostic capabilities, making it increasingly favored in clinical settings.

    Technology: Ultrasound (Dominant) vs. Magnetic Resonance Imaging (Emerging)

    Ultrasound technology stands as the dominant force in the Image Guided Therapy System Market, celebrated for its real-time imaging capabilities, non-invasive nature, and safety. Its wide application in various procedures, including cardiology, obstetrics, and pain management, ensures its continued relevance. Meanwhile, Magnetic Resonance Imaging represents an emerging technology, characterized by its superior imaging resolution and ability to visualize soft tissue structures. With innovations reducing costs and improving accessibility, MRI is poised for significant growth as it becomes integral to personalized medicine.

    By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

    The End User segment of the Image Guided Therapy System Market exhibits a varied distribution among its primary constituents. Hospitals firmly establish themselves as the largest end user, dominant due to their extensive resources, high patient influx, and the ability to invest in advanced imaging technologies. Following hospitals, clinics and ambulatory surgical centers play significant roles, albeit on a smaller scale, due to their focused healthcare services and accessibility to outpatient care. In recent years, ambulatory surgical centers have emerged as the fastest-growing segment within this market, driven by a preference for minimally invasive procedures that allow for shorter recovery times and cost efficiency. Clinics also contribute to growth, as they increasingly adopt image-guided therapies to enhance diagnostic capabilities. The combination of technological advances and an aging population necessitates a shift towards more accessible healthcare delivery models, further energizing this segment.

    Hospitals (Dominant) vs. Research Institutions (Emerging)

    Hospitals are the dominant force in the End User segment of the Image Guided Therapy System Market, recognized for their comprehensive capacity to integrate advanced imaging technologies across various specialties. Their infrastructure supports both complex and routine procedures, catering to a broad patient demographic. Research institutions, on the other hand, are regarded as an emerging category. While they may not match hospitals in terms of volume, they play a critical role in pioneering new techniques and technologies that fuel innovation in image-guided therapies. The collaboration between hospitals and research institutions fosters advancements in device efficacy and procedural protocols, enhancing overall patient care.

    By Product Type: Systems (Largest) vs. Accessories (Fastest-Growing)

    The Image Guided Therapy System Market is characterized by a diverse distribution among its primary product types: systems, software, and accessories. The systems segment dominates this market, taking the largest share due to the increasing reliance on advanced imaging technologies for various therapeutic applications. Meanwhile, accessories, while smaller in share, are on the rise as hospitals look to enhance their existing systems with supportive tools that improve patient outcomes and procedural efficiency.

    Systems (Dominant) vs. Accessories (Emerging)

    The systems segment leads the Image Guided Therapy System Market, driven by technological advancements and a growing need for precision in medical interventions. These systems incorporate sophisticated imaging techniques like MRI, CT, and ultrasound to guide therapies effectively. On the other hand, accessories represent an emerging segment, characterized by rapid innovation and adaptation to facilitate improved user experiences. As healthcare providers increasingly recognize the importance of supplemental tools in standardizing procedures and enhancing patient safety, the accessories market is expected to experience robust growth, attracting significant attention from key stakeholders in the industry.

    Get more detailed insights about Image Guided Therapy System Market

    Regional Insights

    The Regional segmentation of the Global Image Guided Therapy System Market reveals significant variations in market value and potential. In 2024, North America holds a dominant position valued at 2.35 USD Billion, projected to reach 4.65 USD Billion by 2035, showcasing its majority holding in the market driven by advanced healthcare infrastructure and technological adoption.

    Europe follows as a notable segment, valued at 1.5 USD Billion in 2024 and growing to 3.0 USD Billion by 2035, influenced by an increasing focus on minimally invasive surgeries.The APAC region demonstrates robust growth potential, valued at 1.2 USD Billion in 2024 and expected to rise to 2.45 USD Billion by 2035, marking it as a significant player due to rising healthcare demands and economic development. 

    South America, while smaller at 0.25 USD Billion in 2024, shows promising prospects, with a value of 0.5 USD Billion projected for 2035. Meanwhile, the MEA region, comparatively lower at 0.11 USD Billion in 2024 and 0.4 USD Billion by 2035, presents opportunities for market expansion amid improving healthcare standards.These market statistics highlight the diverse landscape of the Global Image Guided Therapy System Market and underscore the critical drivers influencing growth across various regions.

    Image Guided Therapy System Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Image Guided Therapy System Market is witnessing significant advancements driven by ongoing innovations in imaging technology, an increasing prevalence of chronic diseases, and a growing demand for minimally invasive surgical procedures. As healthcare professionals seek more accurate and efficient methods for diagnosing and treating conditions, the competition within this market has intensified. Key players are focusing on enhancing the precision of image-guided therapies by refining imaging technologies and improving system integration. This landscape is characterized by rapid technological advancements, strategic collaborations, and a rising trend of mergers and acquisitions aimed at strengthening market positions and expanding product portfolios. 

    The ongoing research and development activities, coupled with the increasing investments from both public and private sectors, are essential elements driving competitive dynamics and market growth.Olympus Corporation has established a formidable presence within the Global Image Guided Therapy System Market through its innovative imaging solutions and commitment to enhancing surgical outcomes. Renowned for its advanced endoscope technologies and integrated imaging systems, Olympus Corporation leverages its expertise in the medical field to develop products that significantly improve the visualization of anatomical structures during procedures.

    The company's strengths lie in its robust range of laparoscopic and endoscopic imaging tools that facilitate minimally invasive surgeries. 

    Furthermore, Olympus's emphasis on research and development has enabled it to maintain competitiveness and adapt to shifting market demands, ultimately positioning the company as a leader in delivering high-quality imaging solutions tailored for healthcare professionals. The alignment of its strategic goals with emerging trends in healthcare underscores Olympus’s strong foothold in the market.3D Systems has carved a niche within the Global Image Guided Therapy System Market by focusing on the development and implementation of advanced 3D printing technologies that enhance surgical precision and outcomes.

    The company excels in creating custom anatomical models and tissue simulation solutions that help in pre-operative planning and intra-operative navigation. 

    3D Systems leverages its expertise to design innovative imaging systems that facilitate better visualization, accuracy, and efficiency during surgical interventions. Their commitment to technological superiority and customization allows healthcare providers to tailor procedures to individual patient anatomies, thereby improving overall surgical success rates. The company’s proactive approach to addressing the needs of the medical community, along with a strong focus on collaborations and partnerships, positions 3D Systems as an integral player in the evolving landscape of image-guided therapy systems.

    Key Companies in the Image Guided Therapy System Market market include

    Industry Developments

    • Q2 2024: Philips launches next-generation Azurion image-guided therapy platform Philips announced the launch of its next-generation Azurion platform, designed to enhance workflow and clinical capabilities for image-guided therapy procedures. The new system features advanced imaging, workflow automation, and AI-powered decision support tools to improve minimally invasive interventions.
    • Q2 2024: Siemens Healthineers receives FDA clearance for ARTIS icono ceiling, expanding image-guided therapy portfolio Siemens Healthineers announced FDA clearance for its ARTIS icono ceiling system, a ceiling-mounted angiography system designed to support a wide range of minimally invasive, image-guided procedures in interventional radiology, cardiology, and surgery.
    • Q2 2024: GE HealthCare launches Allia IGS Pulse, a new image-guided therapy system for interventional procedures GE HealthCare introduced the Allia IGS Pulse, a new image-guided therapy system that offers enhanced imaging, workflow efficiency, and AI-driven automation for complex interventional procedures in cardiology and oncology.
    • Q2 2024: Boston Scientific announces FDA approval of EXALT Model B Single-Use Bronchoscope for image-guided procedures Boston Scientific received FDA approval for its EXALT Model B Single-Use Bronchoscope, designed to support image-guided bronchoscopy procedures and improve infection control in pulmonary interventions.
    • Q2 2024: Medtronic launches Hugo™ robotic-assisted surgery system with integrated image guidance in Europe Medtronic announced the European launch of its Hugo™ robotic-assisted surgery system, which integrates advanced image guidance to support minimally invasive procedures in urology and gynecology.
    • Q3 2024: Philips and Mayo Clinic announce strategic partnership to advance image-guided therapy innovation Philips and Mayo Clinic entered a multi-year strategic partnership to co-develop and implement next-generation image-guided therapy solutions, focusing on improving patient outcomes in complex cardiovascular and oncological procedures.
    • Q3 2024: Siemens Healthineers opens new manufacturing facility for image-guided therapy systems in Germany Siemens Healthineers inaugurated a new manufacturing facility in Forchheim, Germany, dedicated to the production of advanced image-guided therapy systems to meet growing global demand.
    • Q3 2024: Canon Medical Systems launches Alphenix Sky+, a new angiography system for image-guided therapy Canon Medical Systems introduced the Alphenix Sky+, an advanced angiography system designed to support a broad range of image-guided therapy procedures with improved imaging quality and workflow efficiency.
    • Q4 2024: Philips receives CE mark for SmartCT 3D imaging software for image-guided therapy Philips received CE mark approval for its SmartCT 3D imaging software, enabling enhanced visualization and navigation during image-guided therapy procedures in Europe.
    • Q4 2024: GE HealthCare and Cleveland Clinic announce collaboration to advance image-guided therapy research GE HealthCare and Cleveland Clinic formed a research collaboration to develop and validate new image-guided therapy technologies, aiming to improve precision and outcomes in minimally invasive procedures.
    • Q1 2025: Siemens Healthineers acquires Intuitive Imaging Solutions to expand image-guided therapy capabilities Siemens Healthineers acquired Intuitive Imaging Solutions, a company specializing in advanced imaging software for surgical navigation, to strengthen its image-guided therapy portfolio.
    • Q2 2025: Philips launches Azurion Lung Edition, a dedicated image-guided therapy system for pulmonary interventions Philips introduced the Azurion Lung Edition, a specialized image-guided therapy system designed to support minimally invasive pulmonary procedures with advanced imaging and workflow tools.

    Future Outlook

    Image Guided Therapy System Market Future Outlook

    The Image Guided Therapy System Market is projected to grow at a 6.22% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for minimally invasive procedures, and rising healthcare expenditures.

    New opportunities lie in:

    • Development of AI-driven imaging software for enhanced diagnostic accuracy.
    • Expansion into emerging markets with tailored product offerings.
    • Partnerships with healthcare providers for integrated therapy solutions.

    By 2035, the market is expected to achieve substantial growth, solidifying its position as a leader in medical technology.

    Market Segmentation

    Image Guided Therapy System Market End User Outlook

    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Research Institutions

    Image Guided Therapy System Market Technology Outlook

    • Ultrasound
    • Magnetic Resonance Imaging
    • Computed Tomography
    • Fluoroscopy

    Image Guided Therapy System Market Application Outlook

    • Cardiology
    • Oncology
    • Orthopedics
    • Neurology
    • Gastroenterology

    Image Guided Therapy System Market Product Type Outlook

    • Systems
    • Software
    • Accessories

    Report Scope

    MARKET SIZE 20245.407(USD Billion)
    MARKET SIZE 20255.743(USD Billion)
    MARKET SIZE 203510.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.22% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesIntegration of artificial intelligence enhances precision and efficiency in the Image Guided Therapy System Market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the Image Guided Therapy System Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the Global Image Guided Therapy System Market in 2024?

    The Global Image Guided Therapy System Market is expected to be valued at 5.41 USD Billion in 2024.

    What is the projected market value for the Global Image Guided Therapy System Market by 2035?

    The market is expected to reach a valuation of 10.5 USD Billion by 2035.

    What is the expected CAGR for the Global Image Guided Therapy System Market from 2025 to 2035?

    The expected CAGR for the market from 2025 to 2035 is 6.22%.

    Which application will have the highest market value in the Global Image Guided Therapy System Market by 2035?

    By 2035, the Cardiology application is expected to have the highest market value at 3.15 USD Billion.

    Which region is projected to dominate the Global Image Guided Therapy System Market in 2024?

    North America is projected to dominate the market with a valuation of 2.35 USD Billion in 2024.

    What will be the market size for the Oncology application in 2035?

    The market size for the Oncology application is expected to be 2.06 USD Billion by 2035.

    Who are the key players in the Global Image Guided Therapy System Market?

    Major players include Olympus Corporation, 3D Systems, Karl Storz, Johnson and Johnson, and Siemens Healthineers.

    What is the market size for Neurology in 2024?

    The Neurology segment is valued at 1.18 USD Billion in 2024.

    What is the forecasted market size for the APAC region in 2035?

    The APAC region is forecasted to reach a market size of 2.45 USD Billion by 2035.

    What is the projected value of the Gastroenterology segment by 2035?

    The Gastroenterology segment is projected to grow to 1.14 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions